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Background/introduction
The ability to effectively ablate prostate cancer with
transrectal HIFU has been demonstrated by numerous
publications to date. Early results from focal HIFU series
suggest that side effect profiles such as stricture, erectile
dysfunction, and incontinence can be greatly reduced as
compared to total gland ablative HIFU treatment.
Methods
Multiparametric MRI combined with both systematic
and fusion biopsy is being utilized more frequently
worldwide to select patients for focal therapy.
The ability to effectively ablate prostate cancer with
transrectal HIFU has been demonstrated by numerous
publications to date. Early results from focal HIFU series
suggest that side effect profiles such as stricture, erectile
dysfunction, and incontinence can be greatly reduced as
compared to total gland ablative HIFU treatment. Multi-
parametric MRI combined with both systematic and
fusion biopsy is being utilized more frequently worldwide
to select patients for focal therapy. Commercially available,
FDA approved MRI to ultrasound fusion platforms are
now readily available for use in the urology clinic setting,
however, these have not yet been widely used to guide
focal HIFU treatment. The multistep workflow requires:
1. Creation of a 3D MRI model using MRI images of
the prostate that contain a lesion proven by targeted
biopsy to be malignant;
2. Creation of a 3D model of the prostate using ultra-
sound images, rigid and elastic image fusion; and
3. Use of the fused images to guide treatment.
This process will be demonstrated using clinical exam-
ples and progress on the integration of an MRI to ultra-
sound fusion system into the Sonablate device (Sonacare
Medical) will be described.
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